Compared to T cells from age-matched healthy donors (HD), T cells from CLL patients are skewed towards effector subtypes, have an inverted CD4:CD8 ratio and exhibit reduced immune synapse (IS) formation, activation, proliferation and degranulation potential upon T-cell receptor (TCR) ligation [9–13]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.